- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2 negative, medium-risk, metastatic breast cancer
Total 90507 results
-
Peking Union Medical CollegeUnknownBreast Cancer | HER2 Gene MutationChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
Yuhan CorporationRecruitingHER2-Positive Solid TumorKorea, Republic of, Australia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalActive, not recruitingCAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerGastric Cancer | Esophageal CancerUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Ottawa Hospital Research InstituteCompleted
-
Fondazione del Piemonte per l'OncologiaUnknown
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingGynecological MalignanciesChina
-
Providence Health & ServicesActive, not recruitingBreast CancerUnited States
-
Hoffman OncologyDSCS CROActive, not recruiting
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
UNICANCERMinistry of Health, FranceActive, not recruitingPrimary Non-metastatic Breast Cancer | Who Remain Disease-freeFrance
-
Blokhin's Russian Cancer Research CenterRussian Society of Clinical OncologyCompletedMetastatic Disease | HR+/HER2- Breast Cancer | Аdvanced DiseaseRussian Federation
-
Prof. Wolfgang JanniCompletedHER2-negative Metastatic Breast Cancer | HER2-positive Circulating Tumor CellsGermany
-
Peking UniversityRemeGen Co., Ltd.RecruitingHER2-Positive Solid TumorsChina
-
Bavarian NordicActive, not recruitingChordoma | HER2-positive Breast Cancer | HER2-positive Gastric/Gastroesophageal Junction CancerUnited States
-
Seagen Inc.Array BioPharmaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; GlaxoSmithKline; Brigham and Women's Hospital; North...CompletedBreast Cancer | Stage IV Breast CancerUnited States
-
Peking UniversityJiangsu Alphamab Biopharmaceuticals Co., LtdCompletedHER2 Positive Solid TumorChina
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHER2-positive Recurrent / Metastatic Breast CancerChina
-
GE HealthcareLaboratory Corporation of AmericaNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterPuma Biotechnology, Inc.Active, not recruitingBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMedImmune LLCCompletedMetastatic Breast CancerUnited States
-
Hengrui Therapeutics, Inc.UnknownBreast Cancer | Gastric Cancer | NSCLC | Solid TumorsUnited States
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UnknownSolid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionChina
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedHER2-positive Metastatic Breast CancerChina
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of
-
Celularity IncorporatedActive, not recruitingMetastatic HER2 Positive Gastroesophageal Junction CancerUnited States
-
Tomsk National Research Medical Center of the Russian...Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of SciencesCompletedPrimary Breast CancerRussian Federation
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
AstraZenecaQuintiles; University of Tubingen - GermanyCompletedBreast CancerUnited States, Bulgaria, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Canada, Poland, Australia, Hungary, Taiwan, Japan, Germany, United Kingdom
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.RecruitingA Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the BrainMetastatic Breast CancerUnited States
-
National Cancer Institute, NaplesCompletedMetastatic Breast Cancer
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedHER2-positive Breast CancerChina
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
Dana-Farber Cancer InstituteNovartisCompleted
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingHER2-positive Advanced Solid TumorsChina
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Bio-Thera SolutionsUnknownHER2-Positive Solid TumorsChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
Shengjing HospitalRecruiting
-
UNICANCERActive, not recruiting
-
Spanish Breast Cancer Research GroupRoche Farma, S.ACompleted
-
Ottawa Hospital Research InstituteCompleted
-
Merck Sharp & Dohme LLCTerminatedBreast Cancer | Advanced Solid Tumors
-
Technical University of MunichCompletedBreast Cancer | Gastric CancerGermany
-
Sun Yat-sen UniversityUnknown